Cutting Copays Act
This bill has not become law. Status shown reflects the latest official action.
See what this could mean for your district
Save your district in Account to view district-specific context for this bill.
Bill details
Summary
Introduced in House
Cutting Copays Act This bill eliminates cost-sharing for generic drugs for those with the lowest-income under the Medicare prescription drug benefit's Low-Income Subsidy Program beginning in 2026.
District impact notes
The Cutting Copays Act proposes to eliminate copays for generic drugs for low-income Medicare beneficiaries starting in 2026. • This change could improve access to necessary medications for eligible individuals in the district. • Local healthcare providers may see changes in patient medication adherence and overall health outcomes. • Questions may arise about how this policy will be funded and its impact on the overall Medicare budget. AI-generated from official bill summary and plain-English note; verify with official text.
Related votes
Roll calls that reference this bill in official data.
Primary sources
Official links to verify details. (No interpretation.)
About this data
- OurCongress is non-partisan by design. We do not add political interpretation or advocacy.
- Bill data and official summaries come from GovInfo and Congress.gov. Some bills do not have published summaries yet.
- District impact notes (when shown) are AI-generated from official bill metadata/summaries to improve readability. They are not official government language.
- This page updates automatically via a daily ingestion pipeline.